Aimei Health Technology (NASDAQ:AFJK) Hits New 1-Year High - Time to Buy?

Key Points

• 52-week high: AFJK surged intraday to $98.15 (last $88.50) from a prior close of $8.00 on heavy volume, signaling extreme volatility and speculative trading.
• Analyst sentiment and fundamentals conflict with the rally — Weiss Ratings reiterated a "Sell", the stock's average rating is Sell, it has a very high P/E (421.45) and 50/200-day moving averages around $11, suggesting caution.
• The company currently has no significant operations and is seeking a business combination in biopharma/medtech; institutional investors own about 45.6% and several funds recently adjusted positions, indicating both retail and institutional interest despite the risks.

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Get Free Report)'s stock price hit a new 52-week high on Tuesday . The company traded as high as $98.15 and last traded at $88.50, with a volume of 6428936 shares. The stock had previously closed at $8.00.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a "sell (d+)" rating on shares of Aimei Health Technology in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of "Sell".

Aimei Health Technology Price Performance

The firm has a market capitalization of $541.62 million, a P/E ratio of 421.45 and a beta of 0.03. The business has a 50 day moving average price of $11.26 and a 200 day moving average price of $11.22.

Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last released its earnings results on Tuesday, November 18th. The company reported $0.06 earnings per share (EPS) for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

Large investors have recently bought and sold shares of the stock. Quarry LP grew its position in Aimei Health Technology by 4.7% in the 1st quarter. Quarry LP now owns 157,081 shares of the company's stock worth $1,729,000 after purchasing an additional 7,081 shares during the last quarter. Polar Asset Management Partners Inc. bought a new stake in shares of Aimei Health Technology in the first quarter valued at about $110,000. Wellspring Financial Advisors LLC bought a new stake in shares of Aimei Health Technology in the second quarter valued at about $133,000. Clear Street LLC grew its position in Aimei Health Technology by 63.8% during the second quarter. Clear Street LLC now owns 39,525 shares of the company's stock worth $441,000 after buying an additional 15,399 shares in the last quarter. Finally, Berkley W R Corp grew its position in Aimei Health Technology by 5.9% during the third quarter. Berkley W R Corp now owns 450,655 shares of the company's stock worth $5,101,000 after buying an additional 25,294 shares in the last quarter. 45.58% of the stock is currently owned by institutional investors and hedge funds.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.